{"id":10549,"date":"2026-03-12T09:49:52","date_gmt":"2026-03-12T13:49:52","guid":{"rendered":"https:\/\/www.rigicon.com\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/"},"modified":"2026-03-12T09:49:52","modified_gmt":"2026-03-12T13:49:52","slug":"survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br","status":"publish","type":"clinical-evidence","link":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/","title":{"rendered":"A sobrevida livre de cirurgia de revis\u00e3o da nova pr\u00f3tese peniana infl\u00e1vel de tr\u00eas pe\u00e7as Rigicon Infla10 \u00e9 compar\u00e1vel aos dispositivos anteriores"},"excerpt":{"rendered":"","protected":false},"featured_media":0,"template":"","tags":[],"ce_category":[227],"ce_product":[257],"class_list":["post-10549","clinical-evidence","type-clinical-evidence","status-publish","hentry","ce_category-estudos-de-resultados-clinicos-pt-br","ce_product-infla10-pt-br"],"acf":{"ce_paper_title":"","ce_year":2023,"ce_journal":"Gold Journal","ce_doi":"https:\/\/doi.org\/10.1016\/j.urology.2023.06.031","ce_summary":"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3 anos foi de 94%, demonstrando desempenho compar\u00e1vel \u00e0s IPPs estabelecidas. Produto: Infla10\u00ae.","ce_authors":"Steven K. Wilson, Hodo Haxhimolla, Boon Kua, Gerard Testa, Christopher Love, Mariano Rossello, Alejandro Carvajal, William Lynch, Muhammed A.M. Hammad, Martin Gross","ce_objective":"Avaliar as taxas de cirurgia de revis\u00e3o e a sobrevida do dispositivo da pr\u00f3tese peniana infl\u00e1vel Rigicon Infla10 em uma coorte global.","ce_key_findings":"Entre 535 pacientes, apenas 3,5% necessitaram de revis\u00e3o, principalmente por falha mec\u00e2nica (2,24%). A taxa de sobrevida livre de revis\u00e3o em 3 anos foi de 94%, compar\u00e1vel \u00e0s IPPs concorrentes. As falhas mec\u00e2nicas foram principalmente devidas a vazamento na tubula\u00e7\u00e3o do reservat\u00f3rio.","ce_conclusion":"A Rigicon Infla10 demonstra alta sobrevida do dispositivo e baixas taxas de revis\u00e3o, alinhando-se com os dispositivos estabelecidos, confirmando sua seguran\u00e7a e durabilidade.","ce_clinical_relevance":"Os achados apoiam a Rigicon Infla10 como uma op\u00e7\u00e3o confi\u00e1vel e segura para pacientes com disfun\u00e7\u00e3o er\u00e9til, garantindo aos cl\u00ednicos sua durabilidade livre de revis\u00e3o ao longo de um per\u00edodo de 3 anos.","ce_pdf":null,"ce_logos":null,"ce_featured":true,"ce_keywords":"Infla10\u00ae, pr\u00f3tese peniana, implante infl\u00e1vel, disfun\u00e7\u00e3o er\u00e9til, sobrevida do dispositivo, taxa de revis\u00e3o, falha mec\u00e2nica, urologia"},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.7 (Yoast SEO v27.7) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>A sobrevida livre de cirurgia de revis\u00e3o da nova... - Rigicon\u00ae<\/title>\n<meta name=\"description\" content=\"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/\" \/>\n<meta property=\"og:locale\" content=\"pt_BR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"A sobrevida livre de cirurgia de revis\u00e3o da nova pr\u00f3tese peniana infl\u00e1vel de tr\u00eas pe\u00e7as Rigicon Infla10 \u00e9 compar\u00e1vel aos dispositivos anteriores | Peer-Reviewed Research\" \/>\n<meta property=\"og:description\" content=\"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3 anos foi de 94%, demonstrando desempenho compar\u00e1vel \u00e0s IPPs estabelecidas. Produto: Infla10\u00ae.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/\" \/>\n<meta property=\"og:site_name\" content=\"Rigicon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/rigiconurology\/\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1440\" \/>\n\t<meta property=\"og:image:height\" content=\"718\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@rigiconurology\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\\\/\",\"name\":\"A sobrevida livre de cirurgia de revis\u00e3o da nova... - Rigicon\u00ae\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\"},\"datePublished\":\"2026-03-12T13:49:52+00:00\",\"description\":\"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3...\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\\\/#breadcrumb\"},\"inLanguage\":\"pt-BR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"In\u00edcio\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evid\u00eancia Cl\u00ednica\",\"item\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/clinical-evidence\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"A sobrevida livre de cirurgia de revis\u00e3o da nova pr\u00f3tese peniana infl\u00e1vel de tr\u00eas pe\u00e7as Rigicon Infla10 \u00e9 compar\u00e1vel aos dispositivos anteriores\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#website\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"name\":\"Rigicon\",\"description\":\"Innovative Urological Solutions\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\"},\"alternateName\":\"Innovative Urological Solutions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"pt-BR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#organization\",\"name\":\"Rigicon, Inc.\",\"alternateName\":\"Innovative Urological Solutions\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"pt-BR\",\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"contentUrl\":\"https:\\\/\\\/www.rigicon.com\\\/wp-content\\\/uploads\\\/2024\\\/07\\\/cropped-Logo-Square-Kopya.jpg\",\"width\":512,\"height\":512,\"caption\":\"Rigicon, Inc.\"},\"image\":{\"@id\":\"https:\\\/\\\/www.rigicon.com\\\/pt-br\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/x.com\\\/rigiconurology\",\"https:\\\/\\\/www.instagram.com\\\/rigiconurology\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@Rigicon\\\/podcasts\",\"https:\\\/\\\/www.youtube.com\\\/Rigicon\",\"https:\\\/\\\/www.threads.net\\\/@rigiconurology\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/rigicon\\\/\"],\"description\":\"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.\",\"email\":\"operations@rigicon.com\",\"telephone\":\"+1 (888) 202-9790\",\"legalName\":\"Rigicon, Inc.\",\"vatID\":\"81-3545645\",\"taxID\":\"81-3545645\",\"duns\":\"045247683\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"A sobrevida livre de cirurgia de revis\u00e3o da nova... - Rigicon\u00ae","description":"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/","og_locale":"pt_BR","og_type":"article","og_title":"A sobrevida livre de cirurgia de revis\u00e3o da nova pr\u00f3tese peniana infl\u00e1vel de tr\u00eas pe\u00e7as Rigicon Infla10 \u00e9 compar\u00e1vel aos dispositivos anteriores | Peer-Reviewed Research","og_description":"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3 anos foi de 94%, demonstrando desempenho compar\u00e1vel \u00e0s IPPs estabelecidas. Produto: Infla10\u00ae.","og_url":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/","og_site_name":"Rigicon","article_publisher":"https:\/\/www.facebook.com\/rigiconurology\/","og_image":[{"width":1440,"height":718,"url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2025\/04\/header-d.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_site":"@rigiconurology","schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/","url":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/","name":"A sobrevida livre de cirurgia de revis\u00e3o da nova... - Rigicon\u00ae","isPartOf":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#website"},"datePublished":"2026-03-12T13:49:52+00:00","description":"Este estudo analisou 535 implantes Rigicon Infla10 de 15 pa\u00edses para avaliar as taxas de reopera\u00e7\u00e3o. A sobrevida livre de revis\u00e3o em 3...","breadcrumb":{"@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/#breadcrumb"},"inLanguage":"pt-BR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/survival-from-revision-surgery-for-new-rigicon-infla10-three-piece-inflatable-penile-prosthesis-is-comparable-to-preceding-devices-pt-br\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"In\u00edcio","item":"https:\/\/www.rigicon.com\/pt-br\/"},{"@type":"ListItem","position":2,"name":"Evid\u00eancia Cl\u00ednica","item":"https:\/\/www.rigicon.com\/pt-br\/clinical-evidence\/"},{"@type":"ListItem","position":3,"name":"A sobrevida livre de cirurgia de revis\u00e3o da nova pr\u00f3tese peniana infl\u00e1vel de tr\u00eas pe\u00e7as Rigicon Infla10 \u00e9 compar\u00e1vel aos dispositivos anteriores"}]},{"@type":"WebSite","@id":"https:\/\/www.rigicon.com\/pt-br\/#website","url":"https:\/\/www.rigicon.com\/pt-br\/","name":"Rigicon","description":"Innovative Urological Solutions","publisher":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#organization"},"alternateName":"Innovative Urological Solutions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.rigicon.com\/pt-br\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"pt-BR"},{"@type":"Organization","@id":"https:\/\/www.rigicon.com\/pt-br\/#organization","name":"Rigicon, Inc.","alternateName":"Innovative Urological Solutions","url":"https:\/\/www.rigicon.com\/pt-br\/","logo":{"@type":"ImageObject","inLanguage":"pt-BR","@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/","url":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","contentUrl":"https:\/\/www.rigicon.com\/wp-content\/uploads\/2024\/07\/cropped-Logo-Square-Kopya.jpg","width":512,"height":512,"caption":"Rigicon, Inc."},"image":{"@id":"https:\/\/www.rigicon.com\/pt-br\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/rigiconurology\/","https:\/\/x.com\/rigiconurology","https:\/\/www.instagram.com\/rigiconurology\/","https:\/\/www.youtube.com\/@Rigicon\/podcasts","https:\/\/www.youtube.com\/Rigicon","https:\/\/www.threads.net\/@rigiconurology","https:\/\/www.linkedin.com\/company\/rigicon\/"],"description":"Rigicon is a global provider of innovative, diverse, and complete portfolio of prosthetic urology options.","email":"operations@rigicon.com","telephone":"+1 (888) 202-9790","legalName":"Rigicon, Inc.","vatID":"81-3545645","taxID":"81-3545645","duns":"045247683"}]}},"jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/clinical-evidence\/10549","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/clinical-evidence"}],"about":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/types\/clinical-evidence"}],"wp:attachment":[{"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/media?parent=10549"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/tags?post=10549"},{"taxonomy":"ce_category","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/ce_category?post=10549"},{"taxonomy":"ce_product","embeddable":true,"href":"https:\/\/www.rigicon.com\/pt-br\/wp-json\/wp\/v2\/ce_product?post=10549"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}